Article
Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Clinical and experimental immunology - 1 Nov 2015
Reyes-Castillo Z, Palafox-Sánchez C A, Parra-Rojas I, Martínez-Bonilla G E, del Toro-Arreola S, Ramírez-Dueñas M G, Ocampo-Bermudes G, Muñoz-Valle José F
Abstract excerpt
Antibodies against cyclic citrullinated peptides (anti-CCP) are widely used for diagnosis of rheumatoid arthritis (RA). We performed a comparative analysis of antibodies targeting the citrullinating enzyme peptidylarginine deiminase type 4 (anti-PAD4) and mutated citrullinated vimentin (anti-MCV) with anti-CCP autoantibodies in RA patients and examined their relationships with clinical parameters, cytokine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
